共 50 条
- [21] Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium studyNEURO-ONCOLOGY, 2004, 6 (01) : 15 - 20Laterra, JJGrossman, SACarson, KALesser, GJHochberg, FHGilbert, MR
- [22] Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed GlioblastomaCLINICAL CANCER RESEARCH, 2014, 20 (19) : 5023 - 5031Omuro, AntonioBeal, KathrynGutin, PhilipKarimi, SasanCorrea, Denise D.Kaley, Thomas J.DeAngelis, Lisa M.Chan, Timothy A.Gavrilovic, Igor T.Nolan, CraigHormigo, AdiliaLassman, Andrew B.Mellinghoff, IngoGrommes, ChristianReiner, Anne S.Panageas, Katherine S.Baser, Raymond E.Tabar, VivianePentsova, ElenaSanchez, JuanBarradas-Panchal, RenataZhang, JiananFaivre, GeraldineBrennan, Cameron W.Abrey, Lauren E.Huse, Jason T.
- [23] A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastomaJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Cao, ToniGu, YuanYagmurlu, BanuYerraballa, Hari PriyaBertrand, SophieNaya, LewisMiller, KateIv, MichaelSoltys, Scott G.Patel, Chirag B.Nagpal, SeemaThomas, Reena ParadaBrown, MartinRecht, Lawrence David
- [24] Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiformeJOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2372 - 2377Athanassiou, HSynodinou, MMaragoudakis, EParaskevaidis, MVerigos, CMisailidou, DAntonadou, DSaris, GBeroukas, KKarageorgis, P
- [25] EARLY PROGRESSION BETWEEN SURGERY AND ADJUVANT CHEMO-RADIOTHERAPY IN GLIOBLASTOMANEURO-ONCOLOGY, 2010, 12 : 13 - 14Amelio, D.Farace, P.Ricciardi, G. K.Pizzini, F. B.Zoccatelli, G.Alessandrini, F.Talacchi, A.Amichetti, M.Beltramello, A.
- [26] Radical chemo-radiotherapy for glioblastoma: Outcome and patterns of treatment failureRADIOTHERAPY AND ONCOLOGY, 2015, 115 : S727 - S728Ajithkumar, T.Geater, A. R.Jefferies, S. J.
- [27] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMANEURO-ONCOLOGY, 2022, 24 : 60 - 60Ahluwalia, ManmeetPatel, NehaKhosla, AtulyaRauf, YasmeenStevens, GlenMurphy, ErinChao, SamuelYu, JenniferSuh, JohnPeereboom, David
- [28] PHASE I STUDY OF VANDETANIB WITH RADIATION THERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMANEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634Drappatz, JanNorden, AndrewWong, Eric T.Doherty, LisaLaFrankie, DebraCiampa, AbigailKesari, SantoshSceppa, ChristineGerard, MaryPhan, PhuongLassman, Andrew B.Schiff, DavidBatchelor, TracyLigon, Keith L.Young, GeoffreyMuzikansky, AlonaWeiss, StephanieWen, Patrick Y.
- [29] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMANEURO-ONCOLOGY, 2020, 22 : 37 - 37Rauf, YasmeenPeereboom, DavidFallah, JalehSchilero, CathyLackner, PamelaStevens, GlenAhluwalia, Manmeet
- [30] Phase I study of vandetanib with radiation therapy and temozolomide for newly diagnosed glioblastomaJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Drappatz, J.Norden, A. D.Wong, E. T.Lassman, A. B.Doherty, L.LaFrankie, D.Gerard, M.Phan, P.Schiff, D.Wen, P. Y.